Four things to know:
1. The company’s U.S. revenue was $20.4 million in the first quarter, a 9 percent increase from the same time in 2021, according to a May 9 news release.
2. Milestones for SI-Bone in the first quarter include a new technology add-on payment proposed by CMS and breakthrough device designation for the iFuse Bedrock Granite.
3. The company’s U.S. commercial organization was expanded to 18 sales regions.
4. SI-Bone saw a gross margin of 87 percent in the first quarter. It was affected by lower average selling prices and an increase in operational costs, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
